Q&A with Advarra’s Senior Coordinator of Client Services Jani Viox
For Jani Viox, clinical research is more than a profession—it’s personal. As a senior coordinator of client services at Advarra, Jani […]
Blog
How Smarter Clinical Trial Study Design Decisions Set Studies Up for Faster Startup and Fewer Amendments
Clinical trial study design forms the foundation of trial success. The decisions teams make at the design stage shape how
Why Research Sites Are Switching to Connected eISF and CTMS
Fueled by automation to remove one of the biggest barriers to adoption Increasingly, research sites are not just asking how
New Paper Makes the Case for AI-Specific Guidance in Research Oversight
AI is becoming a routine part of how research proposals are prepared and reviewed, from drafting applications to supporting administrative
Reducing Startup Delays in Oncology Clinical Trials Through Consistent IRB Processes
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive and platform trial models introduce flexibility and shared infrastructure, reducing startup delays, cutting costs, and enabling sponsors to conduct faster, more efficient research.
What Are the Different Types of Study Designs?
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive and platform trial models introduce flexibility and shared infrastructure, reducing startup delays, cutting costs, and enabling sponsors to conduct faster, more efficient research.
Q&A with Senior Manager of Client Services Francine Lopez
For nearly a decade, Francine Lopez has helped clinical research move from idea to impact. From her early days at
Rethinking Oncology Trial Design: Turning Insights from Data and Experience into More Feasible Studies
Oncology research continues to push scientific boundaries, from biomarker-driven therapies to increasingly personalized treatment strategies. Operationally, however, many oncology trials
Insights on the FDA’s ELSA AI And What Changes Next
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive and platform trial models introduce flexibility and shared infrastructure, reducing startup delays, cutting costs, and enabling sponsors to conduct faster, more efficient research.
Preparing for Elsa: What Sponsors, Sites, and CROs Need to Know About the FDA’s New AI Era
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive and platform trial models introduce flexibility and shared infrastructure, reducing startup delays, cutting costs, and enabling sponsors to conduct faster, more efficient research.
Simplifying Oversight and Managing Regulatory Complexity in Multi-Site Clinical Trials
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive and platform trial models introduce flexibility and shared infrastructure, reducing startup delays, cutting costs, and enabling sponsors to conduct faster, more efficient research.
Q&A with Advarra’s Client Experience Team Lead Jennifer DeZurik
Client Experience Team Lead Jennifer DeZurik brings both professional and deeply personal connections to Advarra and the world of clinical